Andreas Kluge

Non-Executive Director / Telix Pharmaceuticals

Dr Kluge has over 20 years of clinical research and development experience, including as Founder, General Manager and Medical Director for ABX-CRO, a full service CRO for Phase I-III biological, radiopharmaceutical and anticancer trials based in Dresden, Germany. He is also Founder and was founding CEO of ABX GmbH (www.abx.de), one of the leading manufacturers of radiopharmaceutical precursors globally. Andreas is further Founder, General Manager and Medical Director for Therapeia, an early stage development company in the field of neurooncology, which was acquired by Telix. Andreas has experience in the practice of Nuclear Medicine and radiochemistry, molecular imaging and the clinical development of novel radionuclide-based products and devices. He is the author of numerous patents and publications in the field of Nuclear Medicine, neurology, infection and immunology.

Lists and Charts

Knowledge Bank : Person Roles

2017

Non-Executive Director

Telix Pharmaceuticals

Year started and most recent title

Total Shareholder Return as at 01/12/25

Rank	Company	1 Yr	5 Yr
1448^th	Gratifii	-38.24%	-34.33%
1449^th	Altech Batteries	-38.3%	-5.91%
1450^th	Telix Pharmaceuticals	-38.48%	33.57%
1451^st	Infinity Metals	-38.71%	-32.93%
1452^nd	HITIQ	-39.03%	0%

View Full List

1675 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Non-Executive Director, Telix Pharmaceuticals

03 Nov 2020

Related Information

Access to our data for Andreas Kluge is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Andreas Kluge is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.